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Abstract
Background: This study aimed to investigate the effects of silk fiber (SF)/calcium phosphate cement (CPC) biocomposite
on repairing radial bone defects in rabbits.
Methods: Four-month-old New Zealand rabbits were selected to create a bilateral radial bone defect model and divided
into four groups according to implanted material: SF/CPC, SF/CPC/particulate bone (PB), PB, and control (C). The specimens
were removed at four and eight postoperative weeks for general observation, X-ray examination, tissue slicing, scanning
electron microscopy (SEM), and biomechanical testing.
Results: Postoperative X-ray showed no bone defect repair in group C and different degrees of bone defect repair in the
other three groups. Imaging, histology, and SEM showed the following: group SF/CPC formed fine trabecular bone in
week 4, while the maximum bending load in group SF/CPC in week 4 was significantly different from those in the
other groups (P < 0.05).
Conclusions: SF/CPC has good biocompatibility and bone-inducing ability, demonstrating its bone defect-repairing ability.
Keywords: Radius, Tissue engineering, Silk fiber, Calcium phosphate cement
Background
Trauma, infection, tumors, and other congenital diseases
have often caused bone defects in recent years [1]. The
purposes of repair and reconstruction are to restore
bone structure and function as quickly and completely
as possible [2]. Therefore, studies of bone tissue
engineering are gradually increasing. Ideal bone defect
repair materials should have the following qualities
[3–5]: (1) sufficient mechanical properties and good
biomechanical adaptation; (2) bone conduction; (3)
osteoinductivity; (4) ability to provide osteoblasts; (5)
ability to directly form bones; (6) good material–bone
interface; and (7) good shapability. Currently, no clin-
ically applied bone repair material can meet all of the
above criteria [6]; however, in clinical application, a
material often just needs to meet some conditions
when used to repair a bone defect, so we can select
suitable materials according to the specific repair
circumstances. Several types of composite materials
are discussed below; however, achieving ideal bone
defect repair is the key in bone tissue engineering.
Autologous bone is the best material for repairing
bone defect and can lead to ideal bone healing. However,
autologous bone is difficult to sample and available in
small quantities, and sampling will inevitably increase
the patient’s pain and risk of infection during the treat-
ment process [7]. Although allogeneic bone can be easily
sampled, its sources are richer than those of autogenous
bone and it has some excellent tissue characteristics like
autologous bone, it normally causes immune rejection
due to antigenic differences among different species;
thus, it has such biosafety risks such as leading to infections
and tumorigenesis. At the same time, sample preparation,
handling, and storage costs are high, so its applications are
greatly limited [8, 9]. Therefore, further research is needed
to find materials that can both meet the mechanical
requirements and achieve ideal bone fusion. Wu et al.
achieved good results with one scaffolding material used in
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the clinical setting [10], but due to its slow degradation,
large cystic characteristic, and insufficient flexibility, its
applications have since been limited. Silk fiber (SF) has a
long history of being used as a natural biological material in
clinics [11], but since it is fine, its aggregation is not guaran-
teed and it exhibits ideal strength only when used in large
amounts. One study [12] used the fiber-reinforcing
principle to add SF to calcium phosphate cement (CPC) for
in vitro experiments and confirmed that SF can enhance
the mechanical strength of CPC. To further study its ability
to repair bone defects, we performed in vivo animal experi-
ments. SF can enhance the mechanical and biological
properties of bone tissue engineering materials as well as
accelerate ossification and repair bone defects.
Methods
Materials and instruments
A total of forty-eight 4-month-old New Zealand rabbits
of either sex (provided by the Experimental Animal
Center, The First Affiliated Hospital of Harbin Medical
University, Harbin, China) with a body weight of 1.8–2.2 kg
were used in the experiment. Mulberry silkworm silk, CPC
(Shanghai Rebone Biomaterials Co., Ltd., Shanghai, China),
anhydrous Na2CO3 (Tianjin Tanggu Chemical Reagent
Factory, Tianjin, China), an Instron5569 universal mechan-
ical testing machine (provided by the School of Materials
Science and Engineering, Harbin Institute of Technology,
Harbin, China), a Faxitron MX 20 Film X-ray machine
(USA), a Thermo HM325 tissue slicer (provided by the
Laboratory of Tissue Engineering, The Second Affiliated
Hospital of Harbin Medical University, Harbin, China), and
a 13 S-3400N scanning electron microscope (provided by
the Laboratory of Electron microscopy, Harbin Medical
University, Harbin, China) were also used. This study was
carried out in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The animal use proto-
col has been reviewed and approved by the Institutional
Animal Care and Use Committee (IACUC) of Harbin
Medical University.
Animal grouping and modeling
The 48 New Zealand rabbits were prepared for the bilat-
eral radial bone defect model: 2 mL/kg chloral hydrate
(10%, m/m) was injected via the ear vein for anesthesia,
and then one 25-mm-long incision was made on the
radial side of the bilateral forelimbs to isolate and expose
the radius; one rongeur was then used to remove
approximately 15 mm of periosteum-containing bone
from the lower radial section. According to different im-
plant materials for the bone defect repair, all of the
models were divided into four groups (n = 12 each): SF/CPC
(implanted SF/CPC biocomposite), SF/CPC/particulate bone
(PB) (implanted SF/CPC biocomposite and tiny particulate
bone), PB (simply implanted tiny particulate bone), and
control (without implanting any materials). All of the
rabbits received a postoperative plaster bandage for
external fixation and were housed in the same envir-
onment; six rabbits in each group were killed in post-
operative weeks 4 and 8 for general observation and
imaging inspection of 12 bone defect sites (bilateral)
at each designed time point, among which eight sites
were also subjected to biomechanical testing and four
were subjected to histology and scanning electron
microscopy (SEM).
Preparation of SF
Cleaned mulberry silks were put into 0.3% sodium
carbonate solution at 100 °C for 30 min and then
washed twice for 10 min using distilled water. Pure SF
strands were cut to 3-mm lengths and conserved after
X-ray irradiation sterilization.
Preparation of PB
After satisfactory anesthesia, each laboratory animal was
placed in the prone position, the skin in the iliac region
was prepared and anesthetized, and paved the sterile
tower. Approximately 1.5 cm × 1.5 cm of iliac bone was
then cut off from one side, and after the soft tissue and
periosteum on the surface were removed, this iliac bone
was fully ground in saline using a drill to 5 mm in diameter;
the bone particle mixture was then filtered using a 500-μm-
diameter mesh, followed by centrifugation at 3000 r/rain
for 5 min (effective centrifugation radius 10 cm); the super-
natant was then removed to obtain bone particle sediment
500 ixm in diameter.
Preparation of SF/CPC biocomposite
SF and CPC were uniformly mixed at a mass ratio of
1:20, to which an appropriate amount of curing liquid
was added to prepare a biocomposite approximately
4 mm in diameter and 15 mm in length. After being
sterilized with ethylene oxide in a fumigation box, the
biocomposite was stored for future use. The same
method was used to mix SF, CPC, and tiny PB with mass




The postoperative general conditions, activities, peripheral
blood supply, and wound infections of the animals were
observed; meanwhile, gentamicin was routinely subcuta-
neously injected to prevent infection. All of the animals
were killed 4 and 8 weeks postoperative, and the bilateral
ulnoradial specimens were removed for visual observation
of the bone defect repair.
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Imaging
The specimens obtained in weeks 4 and 8 (n = 12) were
subjected to X-ray for observation of the formation con-
ditions of new bone or bone callus at the biocomposite
implantation site. The X-ray exposure conditions were
45 kV, 100 mA, and 0.12 s.
Histological observation
The specimens were obtained during weeks 4 and 8 and
included ±5 mm of the normal bone above and below
the biocomposite implantation site. After removal of the
surrounding periosteum and soft tissue, the specimens
were placed in a 4% paraformaldehyde solution (m/m)
for 24-h fixation and then soaked in a 10% ethylenedi-
aminetetraacetic acid solution (m/m) for 4-week decalci-
fication. After thorough removal of the Ca content, the
specimens were subjected to dehydration, hyalinization,
paraffin embedding, slicing, dewaxing, and water rinsing
followed by hematoxylin and eosin staining; the forma-
tion of trabecular bone as well as the growth of bone
cells inside the biocomposite were then observed under
optical microscopy.
Scanning electron microscopy
The specimens obtained during weeks 4 and 8 (n = 12)
were fixed in 3% glutaraldehyde solution (m/m), dried,
and gold-sputtered, followed by SEM observation of the
biocomposite–bone stem interface as well as the ultra-
structure of the newly formed bone.
Biomechanical testing
The fresh radial bone specimens of the three groups
obtained during weeks 4 and 8 (n = 8) were processed by
first removing the surrounding soft tissue and perios-
teum and then retaining the bone ends 1 cm above and
below the bone defect for a three-point bending test
(loading span 10 mm; fulcrum span 16 mm; the
specimen was placed horizontally on the mechanical
testing machine for the detection; the maximum bending
load was set as the measure index to indicate its anti-
bending strength) using one electronic universal testing
machine, and the data were recorded for the following
statistical analysis.
Statistical analysis
SPSS 18.0 statistical software was used, and the
maximum bending load is expressed as x ± s. One-way
analysis of variance was used to compare the max-
imum bending load among groups, while the SNK-q
test was used to make pairwise comparisons among




The visual observation of bilateral radial bone in weeks
4 and 8 revealed that group C had no bone defect
healing at the two time points, whereas the other three
groups exhibited different degrees of bone defect
healing. The defects were detected using SEM, biomech-
anical measurements, histological observations, and
radiographic observations. In week 4, the SF/CPC/PB
group showed better biocomposite–bone combination
and new bone formation than the SF/CPC group, while
the latter showed a less smooth surface; in week 8, the
SF/CPC, SF/CPC/PB, and PB groups all showed better
bone defect healing as well as complete new bone
formation on the bone surface.
Imaging
Group C showed no bone repair at the two postopera-
tive time points and hardened bilateral bone ends on
X-ray imaging. The other three groups exhibited differ-
ent degrees of bone repair: the implanted material
gradually combined with the backbone, and the bone
fracture line gradually disappeared. In week 4, the SF/
CPC group exhibited more trabecular bone disorders,
less of an unobstructed medullary cavity, and poorer
cortical bone continuity than the SF/CPC/PB group
(Fig. 1); in week 8, the boundary lines between the
implanted material and the backbone in the three groups
disappeared, the materials and the bone fully integrated,
the trabecular bone tended to be neat, the cortical
bone was continuous, and the medullary cavity was
recanalized (Fig. 2).
Histological observation
In week 4, the SF/CPC/PB and PB groups exhibited the
ingrowth of a large group of bone cells in the fully
formed trabecular bone and the SF/CPC group exhibited
the formation of a small amount of trabecular bone
(Fig. 3); in week 8, the three groups all exhibited the
growth of a large number of bone cells, while the
trabecular bone was more complete and mature and had
already replaced the interface line (Fig. 4).
Scanning electron microscopy
In week 4, the SF/CPC and SF/CPC/PB groups all exhib-
ited the dressing and deposition of bone along the SF,
while the PB group exhibited more bone deposition
within the trabecular bone and the bone deposition in
the SF/CPC group was less than those in the SF/CPC/
PB and PB groups; the trabecular bones in the three
groups exhibited disorganization at the interface (Fig. 5).
In week 8, the SF/CPC group exhibited gradually
increased bone deposition, while the SF/CPC/PB and PB
groups showed no significant change; the trabecular
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bone tended to be neatly arranged, and SF degradation
was visible. The bone deposition amounts in the three
groups gradually increased with time, the trabecular
bone gradually became remodeled, and the implanted
material–bone end combination became firmer (Fig. 6).
Biomechanical testing
The three-point bending test performed in weeks 4 and
8 showed that, in week 4, the maximum bending load in
the SF/CPC group was significantly different from those
of the SF/CPC/PB and PB groups (P < 0.05, Table 1), but
the difference between SF/CPC/PB and PB was not statis-
tically significant (P > 0.05, Table 1). In week 8, the pair-
wise comparison of maximum bending load among the
three groups showed no statistical significance (P > 0.05,
Table 1). Table 1 shows a comparison of maximum
bending load among the three groups in weeks 4 and 8
(N, mutual ± s, n = 8).
Discussion
Our group previously found that calcium polyphosphate
fibers can improve the mechanical properties of tissue-
engineered bone and provide good bore diameter and
porosity after degradation to facilitate bone ingrowth
and repair based on studies of calcium polyphosphate
fibers, calcium phosphate bone cement, and small-
particle bone repair bone defect. Based on these relevant
studies, we used SF as reinforcing materials to repair
the bone defect due to its good biological properties
[4, 13, 14]. SF is a fibrous protein that is produced
mainly by silkworms and spiders. Its unique mechan-
ical properties, including a tunable biodegradation
Fig. 1 In week 4, X-ray: group SF/CPC exhibits non-complete bone defect repair, the bone cortex is discontinuous, and the interface line of bone ends
is visible (a); group SF/CPC/PB exhibits the completeness of filling material at the bone defect site, new bones are rich, and the bone cortex is fine and
continuous (b); group PB exhibits not-yet-repaired bone defect, but the trabecular bone tends to neat arrangement, and the bone defect exhibits bone
connection (c); and group C exhibits low-density shadow of soft tissue at the bone defect site, and the bone defect is not repaired (d)
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rate and the ability to support the differentiation of
mesenchymal stem cells along the osteogenic lineage,
have made SF a favorable scaffolding material for
bone tissue engineering. SF can be processed into
various scaffold forms, combined synergistically with
other biomaterials to form composites and chemically
modified components, which provides an impressive
toolbox and allows SF scaffolds to be tailored to
specific applications.
This study was based on the fiber-reinforcing principle
in which we prepared SF into short fibers and then
combined it with CPC, so the composite had both
Fig. 2 In week 8, X-ray: group SF/CPC exhibits more complete bone cortex, the interface line between the bone and implant material disappears,
the trabecular bone tends to neat arrangement, the medullary cavity is recanalized, and the shape is good (a); group SF/CPC/PB exhibits complete
bone defect repair, the fusion of the bone ends is complete, the bone cortex is continuous, the medullary cavity is recanalized, and the shape is good
(b); group PB exhibits complete bone defect repair, the bone cortex is continuous, the medullary cavity is recanalized, and the shape is good (c); and
group C exhibits no bone defect repair, and the ends at the bone defect site develop into bone sclerosis (d)
Fig. 3 In week 4, histological examination shows group SF/CPC (a) and SF/CPC/PB (b) have the growth of a large number of bone cells, but the
trabecular bone in group SF/CPC is smaller than group SF/CPC/PB and PB (c), and the structure is blurred (HE staining ×100)
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enhanced rigid strength and increased porosity; further-
more, with the constant degradation of SF in vivo, the
porosity of the biocomposite was further increased,
allowing it to promote bone cell ingrowth, promote Ca
deposition, and accelerate bone replacement, thus facili-
tating the gradual absorbance of bone cement and
achieving the purpose of ideal bone defect repair [15].
At the same time, the addition of SF can reduce the
occurrence of CPC loosening after implantation, reduce
the risk of pulmonary embolism [16, 17], and increase
the safety of CPC.
The use of SF/CPC biocomposite in bone tissue engin-
eering has theoretical and practical feasibility. The tissue
slices in this study showed that, due to the addition of
the small bone particles, the SF/CPC/PB and PB groups
exhibited bone cell growth and trabecular bone forma-
tion in the early experimental stage, and over time, the
trabecular structure tended to be complete and robust,
indicating that bone particles play an important role in
the bone creeping and substitution process [18]. The
SF/CPC group exhibited only slight trabecular bone
formation in week 4, which may have been due to
the following: (1) bone replacement and bone forma-
tion start from the interface and gradually developing
toward the internal portion of the composite and (2)
since the SF/CPC biocomposite lacks bone mesenchy-
mal stem cells (BMSCs) and cell growth factors,
BMSCs gradually migrate into the biocomposite and
then release cell growth factors [19, 20]. In week 8,
histological observation revealed the formation of a
large amount of trabecular bone, indicating that the
SF/CPC biocomposite may meet the bone formation
conditions: (1) when SF degrades in vivo, the porosity
of the composite increases; (2) with gradual BMSC
growth and proliferation, they can continue to release
cell growth factors; and (3) SF itself can induce
vascularization, thus increasing the local nutrient sup-
ply. The biomechanical testing results revealed that,
in week 4, the mechanical strength in the SF/CPC
group was lower than those of the SF/CPC/PB and
PB groups, which may be caused by the structure of
trabecular bone [21, 22]. Since SF will aggregate when
it meets water, it will result in non-uniform distribution of
the implant material; during the bone induction process,
the growth speed of bone cells and the calcification
extents of minerals differ; the SF/CPC/PB and PB groups
exhibited a large range of bone formation in the early
implantation stage, but the trabecular bone in the SF/CPC
group formed earlier and was thinner, thus making it
impossible to achieve the desired mechanical strength. In
week 8, the maximum bending loads among the three
groups showed no significant difference (P > 0.05), indicat-
ing that the SF/CPC group also formed a strong trabecular
structure at this time. During the trabecular bone forma-
tion process, SF constantly biodegrades, thus producing a
variety of amino acids; together with the vasoactive
roles of SF, it is conducive to bone cell growth.
Meanwhile, CPC is also gradually degraded, resulting
Fig. 4 In week 8, histological examination shows group SF/CPC (a), SF/CPC/PB (b), and PB (c) show significantly increased bone lacuna, the
trabecular bone becomes coarse and mature and has clear structure; meanwhile, the blood sinusoid forms clearly (HE staining ×100)
Fig. 5 In week 4, SEM shows that group SF/CPC (a ×450) and SF/CPC/PB (b ×700) shows the dressing and deposition of bone along SF. SF
appears as an irregular shape, the bone deposition in group SF/CPC is less and incomplete than those in group SF/CPC/PB and PB (c ×500), and
no complete trabecular structure can be seen
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in an extracellular environment rich in Ca2+ and P3+,
thus helping increase the Ca deposition among the
pores. This study prepared a new SF/CPC biocompo-
site and verified the biocompatibility and osteoinduc-
tivity of SF in animal experiments. The definition of
bone defect repair is not simply fusion, it also includes
whether the post-fusion mechanical strength is similar to
that of normal tissues (including flexural strength). The
biomechanical testing results in week 8 showed that the
new SF/CPC biocomposite exhibited strength similar to
that of the fine bone particles; therefore, applying SF/CPC
in bone tissue engineering can reduce the requirement of
autologous bone particles to a certain extent. SF/CPC
biocomposites are currently at the basic experimental
stage; although there have been some achievements, it is
not yet widely used in the human body. Many problems
remain to be solved: SF is biodegradable, but how is its
degradation time connected with the speed of osteogen-
esis and when SF is biodegraded more quickly than the
bone is formed, how can we ensure the mechanical
strength of the new material? This study mixed SF and
CPC at a ratio of 1:20 and achieved the desired results,
but the best mixing ratio of SF and CPC remains unclear;
thus, we have yet to determine how we can improve
the porosity of the composite material to improve the
early-stage osteogenesis speed and strength. SF aggre-
gates easily and affects osteogenesis, so we must still
determine how to improve the experimental methods
to reduce the above phenomenon and achieve more
uniform overall bone formation.
Conclusions
In conclusion, our results and those of others suggest
that novel composite self-hardening CPC scaffolds with
fibers have high strength and other favorable character-
istics such as the ability to promote osteogenesis, which
may make this material useful in bone and other
orthopedic repairs. The method of using absorbable
fibers in grafts to provide strength and subsequently
form macropores for bone growth may have wide
applicability in other tissue engineering materials.
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